815 material Form 8-K filings that 659 companies we cover made with the SEC in March 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ormat completed a $1 billion offering of convertible senior notes due March 15, 2031 on March 20, 2026, including $825 million of 1.50% Series A notes and $175 million of 0.00% Series B notes. The company used about $287.9 million of proceeds plus about $25 million of cash on hand to repurchase $285.9 million of its 2.50% convertible notes due 2027, and it plans a separate share repurchase of up to $25 million, which it says is intended to offset dilution from the 2027 notes.
Offering totals $1 billion: $825 million of 1.50% Series A notes and $175 million of 0.00% Series B notes, both due 2031, including full exercise of initial purchasers' options.
Initial conversion price is about $140.40 per share, a premium of about 30% over the last reported sale price on March 17, 2026.
Estimated net proceeds are $975.7 million; about $287.9 million and $25 million cash on hand were used to repurchase $285.9 million of 2027 notes.
Series B noteholders may require repurchase at par on March 15, 2027; the company may not redeem either series before March 20, 2029.
Fair Isaac Corporation closed a $1.0 billion private offering of 6.250% Senior Notes due September 15, 2034. The company plans to use the proceeds to repay credit agreement debt, redeem $400 million of its 5.25% Senior Notes due 2026, pay fees, and for general corporate purposes, including possible stock repurchases.
SUMA Acquisition Corporation, a blank check company, closed its initial public offering of 17,250,000 units at $10.00 each on March 12, 2026, generating gross proceeds of $172,500,000, including full exercise of the underwriters' over-allotment option. The company also sold 446,250 private placement units for $4,462,500 and placed $172,500,000 in a U.S. trust account to be held for a future business combination.
IPO of 17,250,000 units at $10.00 per unit closed March 12, 2026, including 2,250,000 over-allotment units
Private placement of 446,250 units raised $4,462,500, including 141,922 units sold to SUMA Sponsor LP
$172,500,000 placed in trust account with Continental Stock Transfer & Trust Company; the company has 24 months from the IPO closing to complete a business combination
Labcorp and its subsidiary Laboratory Corporation of America Holdings signed a $750 million senior unsecured term loan with Wells Fargo as administrative agent, fully funded on March 20, 2026. The loan matures March 20, 2028 and carries a floating rate of SOFR plus 0.700% or a base rate with a 0% margin. It adds to the company's debt obligations and includes a leverage ratio covenant of 4.0 to 1.0.
$750 million senior unsecured term loan, fully funded on March 20, 2026
Matures March 20, 2028; floating rate of SOFR plus 0.700% or base rate plus 0%
Leverage ratio covenant of not more than 4.0 to 1.0, with a temporary increase to 4.5 to 1.0 allowed after a material acquisition
Wells Fargo Bank, National Association is administrative agent; PNC Bank, National Association is syndication agent
On March 20, 2026, NextEra Energy Capital Holdings, a wholly-owned subsidiary of NextEra Energy, sold $600 million of Series Z Junior Subordinated Debentures due April 15, 2086, bearing 6.50% annual interest paid quarterly. NEE guarantees the debentures on a subordinated basis, and the company may redeem them beginning in April 2031. The filing is mainly a financing disclosure that adds legal opinions and exhibits, and it does not report new earnings or guidance.
Principal amount sold: $600 million of Series Z Junior Subordinated Debentures
Interest rate: 6.50% per year, payable quarterly; maturity April 15, 2086
Optional redemption by the issuer begins in April 2031; NEE provides a subordinated guarantee
Exhibits include legal opinions from Squire Patton Boggs and Morgan, Lewis & Bockius dated March 20, 2026
Columbia Sportswear entered into a new $500 million unsecured revolving credit agreement with JPMorgan Chase Bank on March 19, 2026, maturing March 19, 2031, and terminated its prior 2022 credit agreement at the same time. The company had no outstanding loans under the prior facility, so the change replaces an existing credit line rather than adding debt, though the new terms include a funded debt covenant and limits on dividends and buybacks.
New unsecured revolving credit facility of up to $500 million, maturing March 19, 2031, for working capital and general corporate purposes
Interest set at SOFR plus a margin of 1.00% to 1.50%, or a base rate plus a margin of 0.00% to 0.50%, based on the funded debt ratio
Funded debt ratio covenant of not greater than 3.75 to 1.00; dividends and share buybacks above $200 million annually are restricted if the ratio is 3.25 to 1.00 or higher
Prior Credit Agreement dated July 12, 2022 was terminated; the company had no outstanding loans under it
TG Therapeutics entered a first amendment to its financing agreement on March 18, 2026, establishing a $750 million term loan maturing March 18, 2031, fully borrowed at closing, with part of the proceeds used to repay the existing Initial Term Loans in full. The filing also sets up an uncommitted additional facility of up to $250 million, and the loan is secured by substantially all assets of the company and its guarantor subsidiaries.
$750 million 2026 Term Loan borrowed in full on March 18, 2026, with proceeds partly used to repay Initial Term Loans
Loan matures March 18, 2031; quarterly amortization of $37.5 million begins with the quarter ending March 31, 2030
Pricing grid starts at 4.75% for SOFR borrowings and 3.75% for base rate borrowings, with a 25 basis point step-down tied to leverage
Uncommitted additional facility of up to $250 million; Blue Owl Capital Corporation is administrative agent
Fortive entered into a third amended and restated credit agreement with Bank of America as administrative agent, providing a 5-year revolving credit facility of up to $2.0 billion. The company did not borrow any funds on the closing date, and the facility replaces an agreement dated October 18, 2022 while extending its availability period to March 17, 2031.
Revolving credit facility up to $2.0 billion, dated March 17, 2026, with Bank of America as administrative agent
Maturity extended from October 18, 2027 to March 17, 2031, with up to two one-year extension options
Accordion option for up to an additional $1.0 billion, subject to lender elections and conditions
Maximum Consolidated Net Leverage Ratio of 3.75 to 1.00, rising to 4.25 to 1.00 for four quarters after acquisitions over $250 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.